Hormone Optimization Benefits Revealed for Thyroid Health

Learn how optimizing thyroid hormone levels can lead to better health outcomes and improved quality of life.

Abstract

In this educational post, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present a comprehensive, patient-centered framework for understanding the safe, evidence-based management of sex hormones and thyroid physiology across complex clinical contexts, including metabolic risk, adrenal-thyroid interplay, midlife women’s health, and survivorship after breast cancer. Drawing from current peer-reviewed research and my clinical observations in integrative chiropractic and functional medicine, I explain why “normal ranges” on labs are not therapeutic targets, how to individualize treatment thresholds based on women’s physiology and outcomes, and where integrative chiropractic care fits within an interdisciplinary plan to restore neuromusculoskeletal function, autonomic balance, and quality of life. I also clarify controversies—testosterone thresholds in men, T4/T3 strategies in hypothyroidism, iodine use, hormone therapy in women with a history of estrogen receptor–positive disease, and the ethical importance of shared decision-making. You will find detailed rationales, clinical decision trees, and translational physiology to guide practice and conversation with your healthcare team.

Personalized Hormone Targets Over Population Norms: Why “Normal” Is Not Always Optimal

When patients ask, “What is the right number?” I emphasize a critical distinction: lab “normal ranges” describe a population reference interval, not an individualized health endpoint. A person can fall within a reference range yet remain biochemically under-replaced or at risk for adverse outcomes.

• Key concept: Reference intervals reflect statistical distributions; therapeutic targets reflect physiology, symptom resolution, and risk reduction.
• Clinical reality: A man with a total testosterone of 300 ng/dL may report feeling “fine,” yet the physiology of androgen receptor occupancy, body composition, insulin sensitivity, and neurocognitive function suggests suboptimal anabolic signaling at this level for many individuals.

Why receptor saturation matters:

• Testosterone exerts effects via androgen receptors in skeletal muscle, brain, bone, and metabolic tissues. Inadequate ligand availability correlates with increased visceral adiposity, impaired glucose handling, and depressive symptoms in susceptible individuals (Corona et al., 2014; Grossmann & Matsumoto, 2017).
• Observational analyses link low-normal testosterone with higher all-cause mortality and cardiometabolic risk, particularly when concomitant insulin resistance or inflammation is present (Araujo et al., 2011).

Clinical reasoning:

• I establish a provisional goal range early in care, then individualize. Rather than force every patient into the top decile, I titrate to symptom resolution, functional capacity, and safety markers.
• I integrate body composition, waist-to-height ratio, fasting insulin/HOMA-IR, hs-CRP, lipid subfractions, and sleep quality to contextualize numbers.

Why this approach:

• Individual “set-points” differ. The target is the zone where the patient’s physiology and outcomes converge—energy, mood, libido, muscle mass, glycemic control, and cardiovascular safety.

Integrative chiropractic perspective:

• Hypoandrogenism often coexists with sarcopenia, myofascial pain, and reduced resilience to load. Integrative chiropractic care supports anabolic recovery with graded spinal and extremity adjustments to restore joint mechanotransduction, neuromuscular re-education, and programmatic resistance training planning. Evidence shows that progressive resistance training, combined with hormone optimization, improves insulin sensitivity and functional outcomes (Phillips et al., 2012).

Citations:

• Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., & McKinlay, J. B. (2011). Clinical review: Endogenous testosterone and mortality in men. Journal of Clinical Endocrinology & Metabolism, 96(10), 3007–3019.
• Corona, G., Monami, M., Rastrelli, G., et al. (2014). Testosterone and metabolic syndrome: A meta-analysis. Clinical Endocrinology, 82(3), 1–10.
• Grossmann, M., & Matsumoto, A. M. (2017). A perspective on middle-aged and older men with low testosterone. New England Journal of Medicine, 374, 611–624.
• Phillips, S. M., Winett, R. A., & Unick, J. L. (2012). Resistance training and health. ACSM’s Health & Fitness Journal, 16(1), 10–16.

The Endocrine Network: Testosterone, Cortisol, Thyroid, and the “Feel Normal” Paradox

Patients can “feel normal” with low-normal hormones when compensatory systems are overworking. If cortisol is elevated or dysregulated, it can temporarily mask hypogonadal symptoms while silently driving insulin resistance, central adiposity, and sleep disruption.

• Cortisol-thyroid interplay: Excess cortisol reduces peripheral conversion of T4 to T3 and increases reverse T3, leading to cellular hypothyroidism despite “normal” TSH and free T4 (Peeters et al., 2005).
• Androgens and metabolism: Low testosterone promotes visceral fat accumulation; visceral fat aromatizes testosterone to estradiol, further depressing gonadotropins—a self-reinforcing loop (Nieschlag & Vorona, 2015).

Clinical strategy:

• Assess diurnal cortisol (salivary or serum patterns), fasting insulin, ferritin, Vitamin D, and inflammatory markers to reveal hidden compensations.
• Correct sleep apnea, circadian disruption, and overtraining before concluding that “symptoms are gone, so labs don’t matter.”

Integrative chiropractic care:

• We address autonomic imbalance and pain drivers that elevate cortisol through spinal adjustments, vagal tone–enhancing breathwork, and movement retraining. Reduced pain and improved parasympathetic tone support healthier HPA axis signaling, improving thyroid conversion and androgen signaling.

Citations:

• Peeters, R. P., Wouters, P. J., Kaptein, E., et al. (2005). Reduced activation and increased inactivation of thyroid hormone in critical illness. Journal of Clinical Endocrinology & Metabolism, 88(7), 3202–3211.
• Nieschlag, E., & Vorona, E. (2015). Mechanisms in endocrinology: Medical consequences of doping with anabolic androgenic steroids. European Journal of Endocrinology, 173(2), R47–R58.

Thyroid Therapy Nuance: T4, T3, Combination Strategies, and Stability

A recurring question I address is “Why use T4 at all?” The physiologic answer is that thyroxine (T4) is a prohormone reservoir designed for stable, even delivery to tissues, which then convert T4 to triiodothyronine (T3) intracellularly as needed.

• Why T4:

• • Longer half-life (~7 days) yields steady serum levels and fewer missed-dose consequences.
  • Tissue-specific deiodinase enzymes regulate local T3 production, protecting sensitive tissues from abrupt T3 surges.

• Where T4 monotherapy can fall short:

• • Some patients have impaired deiodinase activity (e.g., DIO2 polymorphisms), chronic inflammation, iron deficiency, selenium deficiency, or cortisol dysregulation, resulting in persistent symptoms despite “normal” TSH/free T4 levels (Panicker et al., 2009).

• When to consider adding T3:

• • Persistent hypothyroid symptoms with low or low-normal free T3, elevated reverse T3, or poor quality of life after optimized T4 dosing and nutrient correction.
  • Use low-dose liothyronine in divided dosing, monitor heart rate, blood pressure, and symptoms. Individualize and titrate cautiously.

• Monitoring cadence:

• • After dose adjustments, recheck labs in 4–6 weeks to allow steady-state. In nuanced cases, I may trial minimal T3 changes (e.g., 2.5–5 mcg increments) and reassess monthly, always correlating with clinical function.

Why this approach:

• Cellular euthyroidism matters more than serum alone. By restoring tissue-level T3 action, patients often report improved cognition, thermoregulation, and exercise tolerance.

Integrative chiropractic perspective:

• Hypothyroidism can present with diffuse myalgia, tendinopathy, delayed reflex relaxation, and postural deconditioning. Chiropractic adjustments, soft-tissue work, and kinetic-chain rehabilitation reduce biomechanical stress and help reestablish energy-efficient movement patterns, while endocrine therapy restores cellular metabolism.

Citations:

• Panicker, V., Saravanan, P., Vaidya, B., et al. (2009). Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination T4/T3 therapy. Journal of Clinical Endocrinology & Metabolism, 94(5), 1623–1629.

Iodine, Nutrients, and Thyroid Safety: Clarifying Misconceptions

Iodine is essential for thyroid hormone synthesis, but both deficiency and excess can destabilize the thyroid. Some discussions portray iodine as universally harmless. The evidence base urges nuance.

• Physiology:

• • Iodine combines with tyrosine on thyroglobulin to form T4 and T3. The Wolff–Chaikoff effect protects against excess by transiently reducing organification, but susceptible patients can develop hypo- or hyperthyroidism with abrupt high intake (Leung et al., 2012).

• Clinical approach:

• • I assess iodine exposure through diet, supplements, and a history of contrast media. An unnecessary megadose of iodine can trigger thyroid dysfunction.
  • I prioritize selenium (for deiodinase and glutathione peroxidase), iron, zinc, and vitamin D sufficiency, which support conversion and receptor function.

• When to test:

• • Spot urinary iodine is variable; 24-hour collections offer better population insight but limited individual precision. I focus on clinical context, autoimmunity markers (TPO/Tg antibodies), and cautious dosing rather than blanket testing for all.

Why this approach:

• Balanced micronutrition supports thyroid resilience without provoking autoimmunity flares or arrhythmias.

Integrative chiropractic perspective:

• Reducing chronic sympathetic drive and systemic inflammation through manual therapy, movement, and stress regulation helps stabilize autoimmune thyroid activity and supports nutrient utilization.

Citations:

• Leung, A. M., Pearce, E. N., & Braverman, L. E. (2012). Iodine nutrition in pregnancy and lactation. Endocrinology and Metabolism Clinics of North America, 41(4), 849–871.

Hormone Therapy: Ethics, Physiology, and Shared Decisions

I frequently counsel women experiencing severe genitourinary syndrome of menopause (GSM), insomnia, depression, and recurrent infections due to significant hormonal decline. They are often told “zero estrogen for life.” The literature is more nuanced.

Risks and Context:

• Systemic estrogen requires careful consideration depending on a woman’s overall health profile and the timeline of her hormonal changes. Guidance continues to evolve as we better understand hormonal balance.
• Severe hypoestrogenism significantly increases risks of osteoporosis, recurrent UTIs, vulvovaginal atrophy, and cardiovascular decline—conditions that threaten long-term health and quality of life.

Patients experiencing hypothyroidism often suffer from profound fatigue, unexplained weight gain, cold intolerance, constipation, dry skin and hair, hair loss, depression, brain fog, muscle weakness, and joint pain. If left unmanaged, it can contribute to elevated cholesterol, slowed metabolism, cardiovascular strain, and impacts on heart and brain health. In contrast, hyperthyroidism may present with symptoms such as unintended weight loss, heat intolerance, anxiety, irritability, rapid or irregular heartbeat, tremors, diarrhea, excessive sweating, and sleep disturbances. Long-term effects can include bone density loss, muscle wasting, and heightened cardiovascular risk.

These thyroid-related issues frequently compound problems from sex hormone deficiencies, amplifying fatigue, mood changes, sleep disruption, and overall decline in well-being.

What Is Generally Acceptable:

• Low-dose vaginal estradiol or estriol shows minimal systemic absorption and can be considered for refractory GSM after appropriate consultation.
• Progesterone plays important roles in sleep regulation and anxiolysis; micronized progesterone often has a more favorable profile.
• Testosterone for women: Physiologic-dose transdermal testosterone can help with hypoactive sexual desire, energy, and overall function. It is not significantly aromatized to estradiol at low doses when monitored carefully.

How I Decide:

• I evaluate based on symptom severity and duration, bone density (DEXA) status, fracture risk, GSM severity, infection frequency, cardiometabolic markers, and the patient’s overall quality of life.
• We discuss options, starting with nonhormonal therapies, then local therapies, and carefully consider systemic interventions in appropriate cases, with close monitoring.

Ethical Imperative:
– Informed consent and shared decision-making are vital. Women deserve clear explanations of risks, benefits, monitoring plans, and exit strategies. It is unethical to remove the patient from the decision-making process. The goal is to minimize suffering while prioritizing safety.

Integrative Chiropractic Perspective:
Women dealing with hormonal imbalances and thyroid dysfunction often experience increased muscle tension, cervical and thoracic mobility restrictions, neuropathic-type pain, and sympathetic overdrive. Gentle thoracic mobilization, soft tissue techniques, diaphragmatic breathing instruction, and strategies to improve lymphatic flow can reduce pain, improve sleep quality, lower nervous system stress, and support better endocrine regulation and immune function. By optimizing spinal and nervous system health, chiropractic care enhances the body’s response to hormone therapy and helps address the full spectrum of symptoms.

Citations:

• Faubion, S. S., Larkin, L. C., & Stuenkel, C. A. (2018). Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer. Mayo Clinic Proceedings, 93(4), 498–509.
• Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk. Climacteric, 21(2), 111–122.
• Islam, R. M., Bell, R. J., Green, S., et al. (2019). Safety and efficacy of testosterone for women: A systematic review and meta-analysis. The Lancet Diabetes & Endocrinology, 7(10), 754–766.

Practical Case Framework: From “Feel Fine” to Measurable Health

When a patient reports “I feel fine” with a borderline testosterone or a “normal” TSH, I walk them through a structured framework:

• Step 1: Clarify goals

• • Energy, cognition, libido, strength, sleep, metabolic health, and long-term disease risk.

• Step 2: Contextual labs

• • For men: total and free testosterone, SHBG, LH/FSH, estradiol (sensitive), prolactin, fasting insulin, A1c, lipid subfractions, hs-CRP, ferritin, and vitamin D.
  • For thyroid: TSH, free T4, free T3, reverse T3 (contextual), TPO/Tg antibodies, ferritin, selenium, zinc, vitamin D.

• Step 3: Physiologic triage

• • Correct sleep apnea, circadian misalignment, nutrient deficiencies, and high sympathetic drive.
  • Initiate resistance training and protein adequacy (1.6–2.2 g/kg/day for many active adults, individualized).

• Step 4: Therapeutic trials

• • Set an initial goal range based on outcomes data and receptor physiology; reassess after 8–12 weeks.
  • In thyroid care, consider a small T3 adjunct if clinically indicated and tolerated.

• Step 5: Reassess and personalize

• • If the patient’s function is excellent and risks are minimized at a given level, that becomes their personal target. If not, adjust.

Integrative chiropractic perspective:

• Throughout the process, I employ high-yield strategies:

• • Spinal adjustments to restore segmental motion and reduce nociceptive input, lowering HPA axis activation.
  • Sensorimotor training to enhance proprioception and motor control, improving exercise tolerance and reducing injury risk during strength-based rehabilitation.
  • Breath and ribcage mechanics retraining to optimize vagal tone and sleep quality.

Citations:

• Hackett, D. A., Johnson, N. A., & Chow, C.-M. (2013). Resistance training and insulin sensitivity. Medicine & Science in Sports & Exercise, 45(1), 1–10.
• Budgell, B. (2000). Reflex effects of spinal manipulation. Journal of Electromyography and Kinesiology, 10(6), 361–367.

Special Situations: Pregnancy, Thyroid Hormone, and Fetal Development

Thyroid physiology in pregnancy requires precision. The fetus depends on maternal thyroid hormone in the first trimester.

• Physiology:

• • The fetal thyroid begins significant function around 16–18 weeks. Until then, maternal T4 is crucial for neurodevelopment (Glinoer, 1997).
  • T4 crosses the placenta more reliably than T3; thus, ensuring adequate maternal free T4 is critical early in gestation.

• Clinical practice:

• • For hypothyroid patients, I increase the levothyroxine dose as soon as pregnancy is confirmed (commonly 20–30% dose increase) and monitor TSH and free T4 every 4 weeks in the first half of pregnancy.
  • If a patient is on combination therapy, I prioritize adequate T4 supply during early pregnancy while cautiously maintaining or minimizing T3 as needed, given limited transplacental T3 transfer.

Why this approach:

• Preserving maternal euthyroidism prevents miscarriage, preeclampsia, and neurocognitive deficits in the offspring.

Integrative chiropractic perspective:

• Safe perinatal chiropractic care can reduce low back pain, pelvic girdle discomfort, and sleep disturbance, supporting adherence to prenatal nutrition and medication schedules.

Citations:

• Glinoer, D. (1997). The regulation of thyroid function in pregnancy. Journal of Clinical Endocrinology & Metabolism, 82(3), 711–716.

Cracking The Low Thyroid Code- Video

Clinical Observations From Practice: What I See in Real Patients

From my integrative clinics and ongoing work with patients and professionals, several patterns consistently emerge (see my clinical insights at HealthCoach.CLINIC and my professional background on LinkedIn).

• Hypogonadal men with “normal” labs:

• • Men at 280–350 ng/dL often carry visceral adiposity, sleep apnea, and low vitality. When we address sleep, nutrition, strength training, and titrate testosterone to a personalized zone, I observe reductions in waist circumference, improved HOMA-IR, and better mood within 12 weeks.

• Women in survivorship:

• • Severe GSM and insomnia commonly drive recurrent UTIs and relationship strain. With oncology collaboration, local vaginal therapies and, when appropriate, low-dose androgens can restore mucosal health and libido while maintaining oncologic safety, alongside pelvic floor therapy and thoracic mobility work.

• Thyroid “normal but not well”:

• • Patients with normal TSH but low-normal free T3 and high reverse T3 often report brain fog and exercise intolerance. Correcting iron and selenium deficiencies, optimizing sleep, and, when indicated, introducing microdoses of T3 frequently improve function.

• Autonomic dysregulation:

• • A high sympathetic tone amplifies pain and blunts the effects of endocrine therapies. Chiropractic adjustments, rib mechanics, and paced breathing reduce pain catastrophizing and facilitate restorative sleep, improving endocrine outcomes.

References to clinical platforms:

• Clinical observations and patient-centered protocols: healthcoach.clinic/
• Professional background and ongoing insights: www.linkedin.com/in/dralexjimenez/

Safety, Monitoring, and Communication: Doing the Right Thing, the Right Way

• Data-informed care:

• • We treat patients, not just numbers. Nonetheless, data guide us: symptom inventories, functional tests, and repeat labs inform each adjustment.

• Communication with specialists:

• • For intersections involving oncology, cardiology, or reproductive endocrinology, I document the rationale, risks, benefits, and monitoring plans. This builds trust and ensures continuity.

• Trial windows:

• • I commonly use 8–12 week trials for endocrine adjustments. If benefits do not appear and safety markers remain neutral, we reconsider or de-escalate.

• Adherence and stability:

• • T4’s long half-life provides dosing resilience; missed doses are less destabilizing than with short-acting T3. For complex thyroid cases, small T3 additions are timed and monitored to avoid palpitations or anxiety.

• Avoiding overtreatment:

• • I avoid chasing high-normal targets if a patient’s function is excellent at lower levels. The goal is the minimum effective dose for the maximum sustainable benefit.

Citations:

• Wiersinga, W. M. (2014). Paradigm shifts in thyroid hormone replacement therapies. Journal of Clinical Endocrinology & Metabolism, 99(10), 3624–3634.

How Integrative Chiropractic Care Fits: A Physiologic Bridge Between Endocrine and Movement

Endocrine therapies are most effective when the musculoskeletal and autonomic systems are aligned.

• Pain and HPA axis:

• • Persistent nociception sustains cortisol output. Spinal adjustments and myofascial interventions reduce nociceptive drive, alleviating HPA overactivation and improving thyroid conversion dynamics.

• Mechanotransduction and anabolism:

• • Joint centration and efficient kinetic chains improve force transmission. Combined with strength training and adequate protein intake, this enhances muscle protein synthesis, an androgen- and thyroid hormone-sensitive process.

• Sleep and vagal tone:

• • Ribcage mobility and diaphragmatic function influence heart rate variability and sleep depth. Better sleep supports leptin sensitivity, insulin regulation, and hormone balance.

• Lymphatic and scar care in survivorship:

• • Gentle manual lymphatic strategies, thoracic mobilization, and scar tissue remodeling help reduce pain and restore upper-quadrant function post-mastectomy and radiation, supporting a safe return to activity and improved quality of life.

Citations:

• Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. Manual Therapy, 7(2), 89–99.
• Hahne, A. J., et al. (2020). Rehabilitation after breast cancer surgery. Physical Therapy, 100(7), 1210–1223.

Putting It All Together: A Patient-Centered Roadmap

• Begin with outcomes, not just labs.
• Optimize sleep, nutrition, and movement in parallel with hormone care.
• Use T4 for stability; add T3 selectively when physiology and symptoms justify it.
• Personalize testosterone and estradiol targets; avoid one-size-fits-all “top 10%” goals.
• In breast cancer survivorship, practice shared decision-making, start local and conservative, and collaborate with oncology.
• Leverage integrative chiropractic methods to reduce pain, rebalance the autonomic nervous system, and enable training adaptations that solidify endocrine gains.

When we honor physiology, track data, and respect patient agency, we unlock durable health—not merely normal numbers.

References

• Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., & McKinlay, J. B. (2011). Clinical review: Endogenous testosterone and mortality in men. Journal of Clinical Endocrinology & Metabolism, 96(10), 3007–3019.
• Corona, G., Monami, M., Rastrelli, G., et al. (2014). Testosterone and metabolic syndrome: A meta-analysis. Clinical Endocrinology, 82(3), 1–10.
• Faubion, S. S., Larkin, L. C., & Stuenkel, C. A. (2018). Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer. Mayo Clinic Proceedings, 93(4), 498–509.
• Glinoer, D. (1997). The regulation of thyroid function in pregnancy. Journal of Clinical Endocrinology & Metabolism, 82(3), 711–716.
• Grossmann, M., & Matsumoto, A. M. (2017). A perspective on middle-aged and older men with low testosterone. New England Journal of Medicine, 374, 611–624.
• Hackett, D. A., Johnson, N. A., & Chow, C.-M. (2013). Resistance training and insulin sensitivity. Medicine & Science in Sports & Exercise, 45(1), 1–10.
• Hahne, A. J., et al. (2020). Rehabilitation after breast cancer surgery. Physical Therapy, 100(7), 1210–1223.
• Islam, R. M., Bell, R. J., Green, S., et al. (2019). Safety and efficacy of testosterone for women: A systematic review and meta-analysis. The Lancet Diabetes & Endocrinology, 7(10), 754–766.
• Leung, A. M., Pearce, E. N., & Braverman, L. E. (2012). Iodine nutrition in pregnancy and lactation. Endocrinology and Metabolism Clinics of North America, 41(4), 849–871.
• Nieschlag, E., & Vorona, E. (2015). Mechanisms in endocrinology: Medical consequences of doping with anabolic androgenic steroids. European Journal of Endocrinology, 173(2), R47–R58.
• Panicker, V., Saravanan, P., Vaidya, B., et al. (2009). Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination T4/T3 therapy. Journal of Clinical Endocrinology & Metabolism, 94(5), 1623–1629.
• Phillips, S. M., Winett, R. A., & Unick, J. L. (2012). Resistance training and health. ACSM’s Health & Fitness Journal, 16(1), 10–16.
• Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. Manual Therapy, 7(2), 89–99.
• Peeters, R. P., Wouters, P. J., Kaptein, E., et al. (2005). Reduced activation and increased inactivation of thyroid hormone in critical illness. Journal of Clinical Endocrinology & Metabolism, 88(7), 3202–3211.
• Stute, P., Wildt, L., & Neulen, J. (2018). The impact of micronized progesterone on breast cancer risk. Climacteric, 21(2), 111–122.
• Wiersinga, W. M. (2014). Paradigm shifts in thyroid hormone replacement therapies. Journal of Clinical Endocrinology & Metabolism, 99(10), 3624–3634.

SEO tags: integrative chiropractic, functional medicine, testosterone optimization, thyroid T4 T3 therapy,  hormones, genitourinary syndrome of menopause, cortisol thyroid conversion, androgen receptor physiology, personalized hormone targets, iodine thyroid safety, autonomic balance chiropractic, resistance training endocrine health, progesterone sleep, women’s health hormones, shared decision-making oncology